On April 12th, New York will receive 112.7 million dollars to aid in helping young people in New York quit using electronic cigarettes.
Electronic cigarette manufacturer Juul has paid a settlement of $462 million in a legal agreement with six states and the District of Columbia. The company was accused of using inappropriate marketing tactics aimed at minors.
Led by Letitia James, Attorney General for the state of New York, and Rob Bonta, Attorney General for California, the company will also be required to classify synthetic nicotine as genuine nicotine, restrict the amount individuals can purchase, and refrain from advertising to individuals under 35 years old.
Related Reading:
1. Juul to pay $462 million in settlement fees to six US states.
E-cigarette company Juul has reached a settlement agreement with the state of West Virginia for $7.9 million. This comes after the company has paid out millions of dollars in settlement fees.
The American brand Juul has agreed to pay $440 million to reach a settlement with various states.
JUUL has spent $18.2 billion in order to reach settlements. The amount and terms of these settlements by state are being reviewed.
2FIRSTS Special Report: Summary of Juul's Settlement Agreement.
Reference:
New York City is set to receive $112 million from JUUL, a popular vape company.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
